The current LXEO market cap is 369.37M. The company's latest EPS is USD -2.4896 and P/E is -5.55.
Quarter End | |||
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | |||
Operating Income | |||
Net Income |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.66M | 654k | 0 |
Operating Income | -50.64M | -60.51M | -68.51M |
Net Income | -50.62M | -59.28M | -66.39M |
Quarter End | |||
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | |||
Total Liabilities | |||
Total Equity |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 136.86M | 97.08M | 139.81M |
Total Liabilities | 7.45M | 25M | 26.27M |
Total Equity | -55.6M | -112.95M | 113.54M |
Market Cap | 369.37M |
Price to Earnings Ratio | -5.55 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.03 |
Price to Book Ratio | 3.25 |
Dividend Yield | - |
Shares Outstanding | 26.67M |
Average Volume (1 week) | 128.98k |
Average Volume (1 Month) | 144.56k |
52 Week Change | 45.79% |
52 Week High | 22.33 |
52 Week Low | 9.00 |
Spread (Intraday) | 3.42 (20.83%) |
Company Name | Lexeo Therapeutics Inc |
Address |
|
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.